Lupin’s US subsidiary - Lupin Pharmaceuticals Inc., has launched its Calcium Acetate Capsules, 667 mg (169 mg Calcium) having received final approval from the United States Food and Drug Administration (USFDA).
Lupin’s Calcium Acetate Capsules, 667 mg (169 mg Calcium) are the AB rated generic equivalent of Fresenius Medical Care North America’s (Fresenius) PhosLo Gelcaps 667 mg (169 mg Calcium) and are indicated for the control of hyperphosphatemia in end stage renal failure. PhosLo Gelcaps had annual US sales of $54.5 million, as per IMS MAT March, 2015.
Lupin is an innovation led transnational pharmaceutical company producing and developing a wide range of branded & generic formulations, biotechnology products and APIs globally. The Company is a significant player in the Cardiovascular, Diabetology, Asthma, Pediatric, CNS, GI, Anti-Infective and NSAID space and holds global leadership positions in the Anti-TB and Cephalosporin segment.
| Company Name | CMP |
|---|---|
| Sun Pharma. Inds. | 1909.05 |
| Dr. Reddys Labs. | 1376.85 |
| Cipla | 1459.40 |
| Zydus Lifesciences | 1135.30 |
| Lupin | 2474.45 |
| View more.. | |
Start Research-backed Investing ...Now. Subscribe to Sapphire
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: